Takara Bio USA and SPT Labtech has announced their partnership to deliver automated library preparation workflows that combine Takara Bio next-gen sequencing library preparation chemistries with SPT Labtech’s firefly liquid handling platform.
Samsung Biologics confirmed that the Seoul High Court has ruled in the company's favour, granting an injunction prohibiting industrial action across all nine core stages of the manufacturing process at its Songdo campus.
Roquette will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place 26-28th October in New Orleans, Louisiana, USA.
Recipharm, a global CDMO, has announced that it has extended its high potency offering at its Leganés site in Spain to GMP pilot scale, giving customers a single high containment route from development to commercial supply.
Cold Chain Technologies (CCT) has helped a global biopharma customer redesign its temperature-controlled shipping strategy, moving from a legacy dry ice-based approach to a right-sized, data-led system that supports sustainability.
QT9 Software, a provider of Quality Management System (QMS) software and Enterprise Resource Planning (ERP) solutions, is showcasing its connected QMS, ERP and BI platforms at PACK EXPO International 2026 in Chicago, Illinois.
Systech has launched the ST33 Carton Serialization Station and ST34 Carton Serialization Station with Tamper Evident—automated systems designed to help pharmaceutical manufacturers packaging line productivity with reduced operational complexity.
Vetter, a global Contract Development and Manufacturing Organisation (CDMO), has received a Red Dot Award in the category "Design Concept" for its next-generation syringe closure system, V-OVS next.
Vaisala will showcase inline liquid concentration measurement solutions at PACK EXPO International 2026, held 18-21 October at McCormick Place in Chicago.
A UK start-up, whose powder transfer valve "solves some of the key challenges facing pharmaceutical manufacturers", has raised over £2.4m to commercialise its technology.
